Your browser doesn't support javascript.
loading
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.
Mercer, Louise; Abhishek, Abhishek; Kavirayani, Akhila; Ahmed, Alison; Davidson, Alan; Foulkes, Amy; Jones, Claire; Nash, Clare; Rose-Parfitt, Emily; Dhillon, Emmandeep; Zabate, Genevieve; Twohig, Helen; De Vere, Hope; Scott, Jennifer; Reynolds, John; Holmes, Julia; Hartley, Karen; Warrier, Kishore; Nowak, Kataryzna; Parsons, Kate; Bechman, Katie; Bray, Lisa; Adikari, Madura; Wood, Natasha; Faithfull, Nicola; Gullick, Nicola; Saha, Pratyasha; Heaton, Rebecca; Deepak, Samundeeswari; Hider, Samantha; Khalid, Sameena; Said, Sanaa Suleiman; Ryan, Sarah; Kyle, Stuart; Raghuvanshi, Subhra; Tan, Su-Yin; Shivamurthy, Vinay; Galloway, James.
Afiliação
  • Mercer L; Department of Rheumatology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK.
  • Abhishek A; Academic Rheumatology, City Hospital Nottingham, University of Nottingham, Nottingham, UK.
  • Kavirayani A; Nottingham NIHR BRC, Nottingham, UK.
  • Ahmed A; Paediatric Rheumatology, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Davidson A; Department of Rheumatology, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton-Under-Lyme, UK.
  • Foulkes A; Community Rheumatology, Modality LLP, Birmingham, UK.
  • Jones C; Department of Dermatopharmacology, Salford Royal NHS Foundation Trust, Salford, UK.
  • Nash C; Medicines Management, Powys Teaching Health Board, Brecon, Powys, UK.
  • Rose-Parfitt E; Pharmacy Department, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Dhillon E; Department of Rheumatology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
  • Zabate G; Department of Rheumatology, New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Twohig H; Rheumatic Diseases Unit, Western General Hospital NHS Lothian, Edinburgh, UK.
  • De Vere H; School of Medicine, Keele University, Keele, UK.
  • Scott J; Department of Rheumatology, Gloucestershire Hospitals NHS Foundation Trust, UK.
  • Reynolds J; Department of Hepatology and Gastroenterology, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK.
  • Holmes J; Institute of Inflammation and Ageing, University of Birmingham Research Labs, Queen Elizabeth Hospital, University of Birmingham, Birmingham, UK.
  • Hartley K; Expert by Experience, Versus Arthritis Fellowship Expert Committee Member.
  • Warrier K; Department of Pharmacy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Nowak K; Paediatric and Adolescent Rheumatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Parsons K; Department of Rheumatology, Belfast Health and Social Care Trust, Belfast, UK.
  • Bechman K; Expert by Experience, UK.
  • Bray L; Centre for Rheumatic Diseases, King's College London, London, UK.
  • Adikari M; Department of Paediatrics, St Richard's Hospital, Chichester, UK.
  • Wood N; Department of Rheumatology, Rotherham General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK.
  • Faithfull N; Brannam Medical Centre, Barnstaple, UK.
  • Gullick N; Childhood Arthritis and Rheumatic Diseases Unit, Birmingham Children's Hospital, Birmingham, UK.
  • Saha P; Department of Rheumatology, University Hospitals Coventry & Warwickshire, Coventry, UK.
  • Heaton R; Department of Rheumatology, Norfolk and Norwich University Hospital, Norfolk, UK.
  • Deepak S; Department of Rheumatology, Stockport NHS Foundation Trust, Stockport, UK.
  • Hider S; Paediatric & Adolescent Rheumatology, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Khalid S; School of Medicine, Keele University, Keele, UK.
  • Said SS; Department of Rheumatology, Haywood Hospital, Midlands Partnership Foundation Trust, Stoke-on-Trent, UK.
  • Ryan S; Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals, Sheffield, UK.
  • Kyle S; Department of Internal Medicine, State University of Zanzibar, Tunguu, Zanzibar, Tanzania.
  • Raghuvanshi S; Department of Rheumatology, Midlands Partnership University NHS Foundation Trust, Stoke-on-Trent, UK.
  • Tan SY; Department of Rheumatology, North Devon District Hospital, Royal Devon University, Devon, UK.
  • Shivamurthy V; Department of Rheumatology, Wrexham Maelor Hospital, Betsi Cadawaladr University Hospital, Wrexham, UK.
  • Galloway J; Department of Rheumatology, NHS Tayside, Dundee, UK.
Rheumatol Adv Pract ; 8(3): rkae077, 2024.
Article em En | MEDLINE | ID: mdl-39006537
ABSTRACT
This guideline will provide up-to-date, evidence-based recommendations on the safe use of non-biologic DMARDs, also called conventional synthetic DMARDs (csDMARD), across the full spectrum of autoimmune rheumatic diseases. The guideline will update the guideline published in 2017 and will be expanded to include people of all ages. Updated information on the monitoring of DMARDs and vaccinations will be included. The guideline will be developed using the methods and processes described in the British Society for Rheumatology's 'Creating clinical guidelines our protocol', updated 2023.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatol Adv Pract Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Rheumatol Adv Pract Ano de publicação: 2024 Tipo de documento: Article